Paydirt
YL
Insider

Yu-Hsin Lin

Chief Executive Officer

Yu-Hsin Lin (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Belite Bio, Inc (BLTE). The largest single filing was $19.1M of BLTE (100,435 sh across 19 lots, as filed), executed Sep 4.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$20.7M
shares × price, as filed
Last traded
Sep 8
Filed Sep 9

Median ADV $34.6M across their filed names

Open performance
Volume by month
$19.1M$9.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $1.6MSep 2026 · sells $19.1M
Buys $0 Sells $20.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
BLTE Belite Bio, Inc BLTE · 0 buys · 2 sells 2 filings
Recent filings
BLTESALE Belite Bio, Inc View filing → $19.1M
100,435 sh across 19 lots
Exec Sep 4
Filed Sep 9 · 7:39 PM ET
BLTESALE Belite Bio, Inc View filing → $1.6M
9,000 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET